Indomethacin increases severity of Clostridium difficile infection in mouse model

Juan Muñoz-Miralles, Bruno C. Trindade, Pablo Castro-Córdova, Ingrid L. Bergin, Leslie A. Kirk, Fernando Gil, David M. Aronoff, Daniel Paredes-Sabja

Producción científica: Contribución a una revistaArtículorevisión exhaustiva

18 Citas (Scopus)

Resumen

Aim: To evaluate the effect on the nonsteroidal anti-inflammatory drug indomethacin on Clostridium difficile infection (CDI) severity. Materials & methods: Indomethacin was administered in two different mouse models of antibiotic-associated CDI in two different facilities, using a low and high dose of indomethacin. Results: Indomethacin administration caused weight loss, increased the signs of severe infection and worsened histopathological damage, leading to 100% mortality during CDI. Indomethacin-treated, antibiotic-exposed mice infected with C. difficile had enhanced intestinal inflammation with increased expression of KC, IL-1β and IL-22 compared with infected mice unexposed to indomethacin. Conclusion: These results demonstrate a negative impact of nonsteroidal anti-inflammatory drugs on antibiotic-associated CDI in mice and suggest that targeting the synthesis or signaling of prostaglandins might be an approach to ameliorating the severity of CDI.

Idioma originalInglés
Páginas (desde-hasta)1271-1281
Número de páginas11
PublicaciónFuture Microbiology
Volumen13
N.º11
DOI
EstadoPublicada - 1 sep. 2018

Áreas temáticas de ASJC Scopus

  • Microbiología
  • Microbiología (médica)

Huella

Profundice en los temas de investigación de 'Indomethacin increases severity of Clostridium difficile infection in mouse model'. En conjunto forman una huella única.

Citar esto